Detalhe da pesquisa
1.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
N Engl J Med
; 381(25): 2403-2415, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562800
2.
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
J Natl Compr Canc Netw
; 20(9): 972-980, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075393
3.
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
BMC Cancer
; 21(1): 510, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957901
4.
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(2): 191-226, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545690
5.
LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?
Gynecol Oncol
; 156(1): 243-250, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703813
6.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Lancet Oncol
; 20(10): 1409-1419, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31474354
7.
First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.
Int J Cancer
; 145(7): 1798-1808, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680712
8.
Nup153 and Nup50 promote recruitment of 53BP1 to DNA repair foci by antagonizing BRCA1-dependent events.
J Cell Sci
; 130(19): 3347-3359, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751496
9.
Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
Gynecol Oncol
; 154(1): 38-44, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029507
10.
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
J Natl Compr Canc Netw
; 17(8): 896-909, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390583
11.
Prognostic factors for rural endometrial cancer patients in a population-based cohort.
BMC Public Health
; 19(1): 921, 2019 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31291920
12.
Too many women are dying from cervix cancer: Problems and solutions.
Gynecol Oncol
; 151(3): 547-554, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301561
13.
Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.
Gynecol Oncol
; 148(3): 499-506, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289418
14.
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.
Int J Gynecol Cancer
; 28(1): 152-160, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28953502
15.
The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers.
Int J Gynecol Cancer
; 2022 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705257
16.
The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care.
Int J Gynecol Cancer
; 27(5): 912-922, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28498257
17.
Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival.
Gynecol Oncol
; 141(3): 421-427, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27005441
18.
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 14(9): 1134-63, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587625
19.
A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-ß, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort.
Invest New Drugs
; 33(6): 1217-24, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26365907
20.
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors.
Invest New Drugs
; 33(3): 691-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25895965